Literature DB >> 6579876

Renal hypoprostaglandism, hypertension, and type IV renal tubular acidosis reversed by furosemide.

S A Sanjad, B S Keenan, L L Hill.   

Abstract

A 13-year-old white girl with severe hypertension and type IV renal tubular acidosis had decreased renal chloride clearance and exaggerated sodium chloride reabsorption by the ascending limb of Henle during hypotonic saline diuresis. Urinary prostaglandin E2 excretion was markedly diminished and often undetectable (0 to 37 ng/24 h). Treatment with oral furosemide completely reversed the hypertension and hyperkalemic acidosis, and effected a 20-fold rise in urinary prostaglandin E2. Sodium chloride reabsorption by the thick ascending limb of Henle decreased from 93.5% to 79.3%. Renal hypoprostaglandism may have a pathogenic role in this syndrome by enhancing chloride reabsorption in the ascending limb of Henle leading to extracellular fluid volume expansion, hypertension, and suppression of the renin-angiotensin-aldosterone axis. The therapeutic effects of furosemide may be partially mediated by enhancing the biosynthesis of renal prostaglandins or inhibiting their breakdown.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6579876     DOI: 10.7326/0003-4819-99-5-624

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  3 in total

1.  "Chloride-shunt" syndrome: an overlooked cause of renal hypercalciuria.

Authors:  J Rodríguez-Soriano; A Vallo; M J Domínguez
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

Review 2.  Renal tubular hyperkalaemia in childhood.

Authors:  J Rodríguez-Soriano; A Vallo
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

3.  The syndrome of hypertension and hyperkalaemia with normal glomerular function (Gordon's syndrome). A pathophysiological study.

Authors:  B Semmekrot; L Monnens; B G Theelen; W Rascher; F Gabreëls; J Willems
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.